Literature DB >> 26289665

Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigen-presenting cells.

B Walch-Rückheim1,2, R Kiefer1, G Geginat3, M J Schmitt1, F Breinig1.   

Abstract

Previous studies underlined the capacity of recombinant yeast as efficient vehicle for the targeted delivery of functional nucleic acids as well as proteinaceous antigens to mammalian antigen-presenting cells (APCs). To improve this yeast-mediated cargo transport into APCs, we investigated the impact of coexpression of the human membrane-perturbing protein perforin in comparison with bacterial listeriolysin O (LLO) on the yeast-based delivery of DNA, mRNA and proteins to mammalian APCs. In contrast to LLO, a cholesterol-dependent pore-forming toxin of Listeria, intracellular expression of human perforin in Saccharomyces cerevisiae had no impact on yeast cell viability, while its coexpression significantly increased translocation of ovalbumin and subsequent activation of ovalbumin-specific T lymphocytes. Likewise, perforin improved the expression of the model antigen enhanced green fluorescent protein after yeast-mediated DNA and mRNA delivery, whereas LLO was only able to enhance DNA delivery. Taken together, our data show that human perforin, besides bacterial hemolysins, represents a promising means to improve the yeast-mediated delivery of functional nucleic acids and proteins to mammalian APCs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26289665     DOI: 10.1038/gt.2015.77

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  29 in total

Review 1.  Delivering the kiss of death: progress on understanding how perforin works.

Authors:  Matthew E Pipkin; Judy Lieberman
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

2.  Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.

Authors:  A C Stubbs; K S Martin; C Coeshott; S V Skaates; D R Kuritzkes; D Bellgrau; A Franzusoff; R C Duke; C C Wilson
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

3.  Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.

Authors:  Elizabeth K Wansley; Mala Chakraborty; Kenneth W Hance; Michael B Bernstein; Amanda L Boehm; Zhimin Guo; Deborah Quick; Alex Franzusoff; John W Greiner; Jeffrey Schlom; James W Hodge
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

4.  Yeast/E. coli shuttle vectors with multiple unique restriction sites.

Authors:  J E Hill; A M Myers; T J Koerner; A Tzagoloff
Journal:  Yeast       Date:  1986-09       Impact factor: 3.239

5.  Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation.

Authors:  Sunil S Metkar; Baikun Wang; Miguel Aguilar-Santelises; Srikumar M Raja; Lars Uhlin-Hansen; Eckhard Podack; Joseph A Trapani; Christopher J Froelich
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

6.  Bacterial delivery of functional messenger RNA to mammalian cells.

Authors:  Christoph Schoen; Annette Kolb-Mäurer; Gernot Geginat; Daniela Löffler; Birgit Bergmann; Jochen Stritzker; Aladar A Szalay; Sabine Pilgrim; Werner Goebel
Journal:  Cell Microbiol       Date:  2005-05       Impact factor: 3.715

Review 7.  Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity.

Authors:  B Lowin; M C Peitsch; J Tschopp
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

8.  Schizosaccharomyces pombe: a novel transport vehicle of functional DNA and mRNA into mammalian antigen-presenting cells.

Authors:  Barbara Walch-Rückheim; Manfred J Schmitt; Frank Breinig
Journal:  Vaccine       Date:  2014-09-17       Impact factor: 3.641

9.  The glyoxylate cycle is required for fungal virulence.

Authors:  M C Lorenz; G R Fink
Journal:  Nature       Date:  2001-07-05       Impact factor: 49.962

10.  Liposomes as targets for granule cytolysin from cytotoxic large granular lymphocyte tumors.

Authors:  R Blumenthal; P J Millard; M P Henkart; C W Reynolds; P A Henkart
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more
  2 in total

1.  Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype.

Authors:  Michelle Seif; Anja Philippi; Frank Breinig; Alexandra K Kiemer; Jessica Hoppstädter
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

Review 2.  Yeasts in nanotechnology-enabled oral vaccine and gene delivery.

Authors:  Elena Ivanova
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.